Bone Proteins Exorbitantly Costly

A report in this week’s edition of the Journal of the American Medical Association (JAMA) notes the skyrocketing costs of using bone proteins over conventional surgeries.
The study concludes that costs increased anywhere from 11% to 41% nationwide when the bone proteins were used.
This news comes on the heels of reports that Medtronic’s Infuse bone graft aren’t as effective as previously thought. It has come to light that the doctor who was touting Medtronic’s Infuse product was padding his results and forged the signatures of other doctors on a medical research report outlining the benefits of Infuse.
So, what we’re left with is a questionable medical device that’s outrageously expensive. In the end, the cost is passed on to the consumer who’s relying on the integrity and experience of the doctor using the medical device. The doctor, in turn, is relying on the accuracy of reports he/she has read about that medical device.
Like most industries, trust is a key factor. If one constituency can’t rely on the accuracy and integrity of another group, the whole system collapses. Medical devices and pharmaceutical drugs have to be tested and independently shown to be effective and reliable. If consumers don’t have that confidence, the healthcare system is in peril.